T38.812S Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm, sequela

Name of the Condition

• Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm, sequela

Summary

This condition describes the residual effects of intentional self-harm resulting from poisoning by anterior pituitary hormones, occurring during the sequela phase. It applies when the exposure was deliberate, and the effects persist beyond the acute phase of the injury. The code captures long-term consequences or complications arising from the initial poisoning event.

Causes

The causes involve intentional exposure to anterior pituitary hormones, their synthetic analogues, or antagonists, with the intent to cause self-harm. The sequela phase reflects ongoing or chronic effects resulting from the initial poisoning, such as persistent endocrine dysfunction, organ damage, or other lasting impairments.

Risk Factors

• History of intentional self-harm or suicidal behavior
• Access to anterior pituitary hormone therapies or substitutes
• Mental health conditions affecting judgment or impulse control
• Polypharmacy involving hormonal agents
• Individual sensitivity to hormonal substances

Symptoms

Symptoms depend on the specific hormone involved and may include persistent metabolic disturbances, endocrine imbalances, or organ-specific effects. Long-term consequences could manifest as chronic hyper- or hypofunction of target systems, ongoing organ damage, or other residual impairments from the initial poisoning.

Diagnosis

Diagnosis involves reviewing the patient’s history of intentional self-harm, confirming exposure to anterior pituitary hormones, and identifying residual effects. Clinical evaluation, laboratory tests, and imaging may be used to assess ongoing complications or chronic conditions resulting from the initial poisoning.

Treatment Options

Treatment focuses on managing residual effects and preventing further harm. This may include ongoing endocrine management, organ-specific therapies, psychological support, and monitoring for recurrent self-harm. Interventions are tailored to address the specific complications present.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial poisoning and the nature of residual effects. Follow-up care is essential to monitor for complications, adjust treatments, and provide ongoing support. Regular assessments help ensure stability and address any emerging issues.

Complications

Complications may include chronic endocrine disorders, organ damage, psychological sequelae, or recurrent self-harm. Long-term effects can vary based on the specific hormone involved and the extent of initial injury.

Lifestyle & Prevention

Lifestyle modifications may support recovery, such as adhering to prescribed therapies, avoiding triggers, and maintaining mental health support. Prevention strategies include securing hormonal agents, reducing access to means of self-harm, and addressing underlying mental health conditions.

When to Seek Professional Help

Seek professional help if new or worsening symptoms occur, such as severe metabolic changes, organ dysfunction, or signs of recurrent self-harm. Prompt evaluation is important for managing complications and adjusting care plans.

Tips for Medical Coders

Document the sequela phase clearly, including the nature of residual effects and their relationship to the initial intentional self-harm event. Ensure the code is used only when the condition represents a residual effect of the poisoning, not the acute phase. Verify that the intent (intentional self-harm) and the specific hormone category are accurately reflected in the record.